| Name | 3-(2-methoxy-3-nitrophenyl)benzoic acid |
|---|---|
| Synonyms |
Eltrombopag Impurity
Eltrombopag Olamine Impurity 4 2'-Methoxy-3'-nitro-3-biphenylcboxylic acid BIP028 [1,1'-Biphenyl]-3-cboxylic acid, 2'-methoxy-3'-nitro Eltrombopag Impurity 45 Eltrombopag olamine Intermediate 3 2'-methoxy-3'-nitrobiphenyl-3-carboxylic acid 2'-Methoxy-3'-nitro-[1,1'-biphenyl]-3-cboxylic acid [1,1'-Biphenyl]-3-carboxylic acid,2'-methoxy-3'-nitro 2'-Methoxy-3'-nitro-biphenyl-3-cboxylic acid Eltrombopag Impurity 20 |
| Density | 1.345±0.06 g/cm3 |
|---|---|
| Boiling Point | 467.2±40.0℃at 760 mmHg |
| Molecular Formula | C14H11NO5 |
| Molecular Weight | 273.24100 |
| Exact Mass | 273.06400 |
| PSA | 92.35000 |
| LogP | 3.49180 |
|
~%
376591-94-5 |
| Literature: Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co. Ltd. Patent: EP2236500 A1, 2010 ; Location in patent: Page/Page column 15 ; |
|
~%
376591-94-5 |
| Literature: Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co. Ltd. Patent: EP2441457 A1, 2012 ; |
|
~%
376591-94-5 |
| Literature: Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co. Ltd. Patent: EP2441457 A1, 2012 ; |
| Precursor 4 | |
|---|---|
| DownStream 1 | |